The evolving landscape of pathology is now digital, generating a wealth of untapped data and creating a new data modality from which life sciences can extract valuable insights. This shift is transformative to accelerate precision medicine drug discovery, development, and ultimately delivery to patients.

Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, more than doubled its growth in 2024. The company enters 2025 having cemented its leadership position, with life sciences organizations and diagnostic laboratories increasingly deploying its Concentriq® enterprise pathology platform to advance the next novel therapies and diagnostics.

Building AI models for tissue classification in histopathology has traditionally meant assembling large, hand-annotated datasets—a time-consuming and resource-heavy process. But what if you didn’t need those massive datasets? With Concentriq Embeddings and PLIP, a multimodal vision-language foundation model, you can build a zero-shot tissue classification model in minutes—no annotated training data required.